Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID05222594

Computational Neuroscience of Language Processing in the Human Brain

Led by Massachusetts General Hospital · Updated on 2026-05-07

40

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

M

Massachusetts General Hospital

Lead Sponsor

M

Massachusetts Institute of Technology

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are investigating how the human brain processes language by studying neural responses in patients with epilepsy undergoing intracranial monitoring. This study aims to combine detailed brain recordings with computational models to better understand how the brain extracts meaning from speech and sequences of words, focusing on specific brain areas involved in language. Participants are patients with epilepsy who require intracranial monitoring involving the left side of the brain. During the monitoring period, which can last up to about 10 days, participants will listen to sentences and stories while their brain activity is recorded through electrodes placed for clinical reasons. These recordings will help map language processing in the brain and compare it to artificial neural network models. Throughout the study, researchers will collect detailed brain activity data related to language comprehension and analyze cortical maps and neural time-courses during natural speech understanding. Participants will be assessed during their clinical monitoring period, and the study focuses on understanding brain responses rather than testing new treatments. The total participation time aligns with the clinical monitoring duration, and the study includes informed consent and task compliance assessments.

CONDITIONS

Brief Title

Computational Neuroscience of Language Processing in the Human Brain

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Clinical indications to proceed with intracranial monitoring involving the left cerebral hemisphere, as determined by a multidisciplinary epilepsy surgery team
  • Ability to comply with test directions and provide informed consent
  • Between ages 18 and 85 years
Not Eligible

You will not qualify if you...

  • Inability to understand or perform the task outlined in the protocol
  • Unwillingness or inability to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - Up to approximately 10 days

Participants undergo intracranial monitoring while listening to sentences and stories during behavioral tasks. Neural data are recorded through electrodes placed for clinical purposes.

Continuous monitoring throughout up to 10 days

Trial Site Locations

Total: 1 location

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

Loading map...

Research Team

E

Evelina Fedorenko, PhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

BASIC_SCIENCE

Number of Arms

1

Similar Trials

An Open-label, Long-term Study Evaluating RAP-219 in Adult P...

Focal Epilepsy

Actively Recruiting

7 locations

Features of the Gut Microbiota in Patients With Critical Chr...

Essential Hypertension

Actively Recruiting

50 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Lexical and syntactic representations in the brain: an fMRI investigation with multi-voxel pattern analyses.

Evelina Fedorenko, Alfonso Nieto-Castañon, Nancy Kanwisher

https://pubmed.ncbi.nlm.nih.gov/21945850